Showing results (31-40 of 152) with videos related to

Sort By:
Pageof 16
Oncoimmunology|October 24, 2014
Bone marrow-derived CD13<sup>+</sup> cells sustain tumor progression: A potential non-malignant target for anticancer therapyEleonora Dondossola, Angelo Corti, Richard L Sidman, et al.
Nano Research|May 27, 2016
NGR-tagged nano-gold: A new CD13-selective carrier for cytokine delivery to tumorsFlavio Curnis, Martina Fiocchi, Angelina Sacchi, et al.
Cancer Research|April 5, 2005
Targeted delivery of IFNgamma to tumor vessels uncouples antitumor from counterregulatory mechanismsFlavio Curnis, Anna Gasparri, Angelina Sacchi, et al.
Cancer Research|February 7, 2002
Chromogranin A expression in neoplastic cells affects tumor growth and morphogenesis in mouse modelsBarbara Colombo, Flavio Curnis, Chiara Foglieni, et al.
Basic Research in Cardiology|September 10, 2005
Recombinant N-terminal fragments of chromogranin-A modulate cardiac function of the Langendorff-perfused rat heartMaria Carmela Cerra, Lucia De Iuri, Tommaso Angelone, et al.
Proteomics|August 13, 2005
Peptide microarrays for the characterization of antigenic regions of human chromogranin AMarcella Chiari, Marina Cretich, Angelo Corti, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 10, 2011
The vasostatin-1 fragment of chromogranin A preserves a quiescent phenotype in hypoxia-driven endothelial cells and regulates tumor neovascularizationLorenzo Veschini, Luca Crippa, Eleonora Dondossola, et al.
Journal of Molecular Neuroscience : MN|March 6, 2012
Chromogranin A and derived peptides in health and diseaseY Peng Loh, Yong Cheng, Sushil K Mahata, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 13, 2012
IsoDGR-tagged albumin: a new αvβ3 selective carrier for nanodrug delivery to tumorsFlavio Curnis, Angelina Sacchi, Renato Longhi, et al.
Pageof 16